Vitiligo is a dermal disease, characterized by skin depigmentation due to the lack of melanocytes. Depigmented skin has a negative impact on a psychological level as well. Dermal patches are usually located on hands and face.
It is challenging to handle and it is linked to genetic and/or immunity defects.
Vitiligo needs the intervention of a specialised dermatologist. It can be diagnosed during its active phase and it can remain stable for many years, without growing or expanding.
The Rigenera Technology consists of a minimally invasive procedure. The entire procedure occurs in one surgical time and lasts for about 30 minutes. The whole procedure can be managed in a private practice by a physician, who has received a dedicated training.
In an autologous, homologous and minimally invasive manner where the patient is both donor and acceptor.
The micrografts are obtained starting from small fragments of tissue harvested using a dermal punch, and then mechanically disaggregated with the Rigeneracons medical device. The processed tissue can be then used as a micrograft.
After the application of micrografts, skin characteristics improve, so it is demonstrated that the application of Rigenera helps to improve the repigmentation of depigmented patches.
After using Rigenera, scientific applications showed a good association with UV lamp photostimulation.
Over time, the number of scientific contributions about the applications of the Rigenera Technology to the field of Dermatology and Aesthetics has grown. Scientific papers represent a tangible testimony of the practical applications of Rigenera.
You can find out more about our: